Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage

NCT01496014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 646

Last updated 2026-05-05

No results posted yet for this study

Summary

The purpose of this study is to characterize the bacteria in the wound "bioburden" at the time of definitive wound coverage/closure of severe tibia fractures in both the military and civilian populations.

Conditions

  • Open Fracture

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • Major Extremity Trauma Research Consortium

    lead OTHER

Principal Investigators

  • Michael J Bosse, MD · Carolinas Medical Center

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2016-09-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01496014 on ClinicalTrials.gov